Induced pluripotent stem cell-derived myeloid phagocytes: Disease modeling and therapeutic applications

Drug Discovery Today

Volumn 19, Issue 6, 2014, Pages 774-780

  Goodridge, Helen S ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC GRANULOMATOUS DISEASE; CINCA SYNDROME; DENDRITIC CELL; DISEASE MODEL; GAUCHER DISEASE; HEMATOPOIETIC STEM CELL; HUMAN; MACROPHAGE; MONOCYTE; MYELOPROLIFERATIVE DISORDER; NEUTROPHIL; NONHUMAN; PHAGOCYTE; PLURIPOTENT STEM CELL; REVIEW; SEVERE CONGENITAL NEUTROPENIA; ANIMAL; MYELOPROLIFERATIVE DISORDERS; PATHOLOGY; PHYSIOLOGY; TRANSPLANTATION;

ANIMALS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; MACROPHAGES; MYELOPROLIFERATIVE DISORDERS; PHAGOCYTES;

EID: 84902113157     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.01.004     Document Type: Review

References (43)

1. W.F. Lim et al. Hematopoietic cell differentiation from embryonic and induced pluripotent stem cells Stem Cell Res. Ther. 4 2013 71
2. A.B. Cherry, and G.Q. Daley Reprogrammed cells for disease modeling and regenerative medicine Annu. Rev. Med. 64 2013 277 290
3. K.D. Choi et al. Hematopoietic differentiation and production of mature myeloid cells from human pluripotent stem cells Nat. Protoc. 6 2011 296 313
4. Y. Jiang et al. Derivation and functional analysis of patient-specific induced pluripotent stem cells as an in vitro model of chronic granulomatous disease Stem Cells 30 2012 599 611
5. S. Mukherjee et al. Generation of functional neutrophils from a mouse model of X-linked chronic granulomatous disorder using induced pluripotent stem cells PLoS ONE 6 2011 e17565
6. J. Zou et al. Oxidase-deficient neutrophils from X-linked chronic granulomatous disease iPS cells: functional correction by zinc finger nuclease-mediated safe harbor targeting Blood 117 2011 5561 5572
7. D.S. Grenda et al. Mice expressing a neutrophil elastase mutation derived from patients with severe congenital neutropenia have normal granulopoiesis Blood 100 2002 3221 3228 (Pubitemid 35217070)
8. S. Nanua et al. Activation of the unfolded protein response is associated with impaired granulopoiesis in transgenic mice expressing mutant Elane Blood 117 2011 3539 3547
9. T. Hiramoto et al. Wnt3a stimulates maturation of impaired neutrophils developed from severe congenital neutropenia patient-derived pluripotent stem cells Proc. Natl. Acad. Sci. U. S. A. 110 2013 3023 3028
10. I. Kollner et al. Mutations in neutrophil elastase causing congenital neutropenia lead to cytoplasmic protein accumulation and induction of the unfolded protein response Blood 108 2006 493 500 (Pubitemid 44061347)
11. J.R. Chao et al. Hax1-mediated processing of HtrA2 by Parl allows survival of lymphocytes and neurons Nature 452 2008 98 102
12. T. Morishima et al. Genetic correction of HAX1 in induced pluripotent stem cells from a patient with severe congenital neutropenia improves defective granulopoiesis Haematologica 99 2014 (Epub ahead of print)
13. T. Tanaka et al. Induced pluripotent stem cells from CINCA syndrome patients as a model for dissecting somatic mosaicism and drug discovery Blood 120 2012 1299 1308
14. L.M. Panicker et al. Induced pluripotent stem cell model recapitulates pathologic hallmarks of Gaucher disease Proc. Natl. Acad. Sci. U. S. A. 109 2012 18054 18059
15. J.E. Carette et al. Generation of iPSCs from cultured human malignant cells Blood 115 2010 4039 4042
16. S.T. Chou et al. Trisomy 21-associated defects in human primitive hematopoiesis revealed through induced pluripotent stem cells Proc. Natl. Acad. Sci. U. S. A. 109 2012 17573 17578
17. S. Gandre-Babbe et al. Patient-derived induced pluripotent stem cells recapitulate hematopoietic abnormalities of juvenile myelomonocytic leukemia Blood 121 2013 4925 4929
18. K. Hu, and I. Slukvin Generation of transgene-free iPSC lines from human normal and neoplastic blood cells using episomal vectors Methods Mol. Biol. 997 2013 163 176
19. K. Hu et al. Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells Blood 117 2011 109 119
20. K. Kumano et al. Generation of induced pluripotent stem cells from primary chronic myelogenous leukemia patient samples Blood 119 2012 6234 6242
21. K. Kumano et al. Generation of iPS cells from normal and malignant hematopoietic cells Int. J. Hematol. 98 2013 145 152
22. G.A. Maclean et al. Altered hematopoiesis in trisomy 21 as revealed through in vitro differentiation of isogenic human pluripotent cells Proc. Natl. Acad. Sci. U. S. A. 109 2012 17567 17572
23. I.H. Park et al. Disease-specific induced pluripotent stem cells Cell 134 2008 877 886
24. Z. Ye et al. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders Blood 114 2009 5473 5480
25. R.J. Chan, and M.C. Yoder JMML patient-derived iPSCs induce new hypotheses Blood 121 2013 4815 4817
26. T. Chang et al. Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice J. Clin. Invest. 123 2013 335 339
27. X. Liu et al. Molecular targets for the treatment of juvenile myelomonocytic leukemia Adv. Hematol. 2012 2012 308252
28. H. Iwamoto et al. Antitumor immune response of dendritic cells (DCs) expressing tumor-associated antigens derived from induced pluripotent stem cells: in comparison to bone marrow-derived DCs Int. J. Cancer 2013 10.1002/ijc.28367
29. K.M. Silk et al. Cross-presentation of tumour antigens by human induced pluripotent stem cell-derived CD141(+)XCR1+ dendritic cells Gene Ther. 19 2012 1035 1040
30. L.D. Notarangelo Correcting CGD safely, iPSo facto Blood 117 2011 5554 5556
31. S. Senju et al. Characterization of dendritic cells and macrophages generated by directed differentiation from mouse induced pluripotent stem cells Stem Cells 27 2009 1021 1031
32. S. Senju et al. Generation of dendritic cells and macrophages from human induced pluripotent stem cells aiming at cell therapy Gene Ther. 18 2011 874 883
33. A. Kambal et al. Generation of HIV-1 resistant and functional macrophages from hematopoietic stem cell-derived induced pluripotent stem cells Mol. Ther. 19 2011 584 593
34. M. Jerebtsova et al. HIV-1 resistant CDK2-knockdown macrophage-like cells generated from 293T cell-derived human induced pluripotent stem cells Biology (Basel) 1 2012 175 195
35. M. Haruta et al. TAP-deficient human iPS cell-derived myeloid cell lines as unlimited cell source for dendritic cell-like antigen-presenting cells Gene Ther. 20 2013 504 513
36. J. Bilic, and J.C. Izpisua Belmonte Concise review: induced pluripotent stem cells versus embryonic stem cells: close enough or yet too far apart? Stem Cells 30 2012 33 41
37. D.S. Kaufman Tu-mor(e) blood cells from human pluripotent stem cells Blood 121 2013 1245 1246
38. A.S. Lee et al. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies Nat. Med. 19 2013 998 1004
39. I.P. Chen et al. Induced pluripotent stem cell reprogramming by integration-free sendai virus vectors from peripheral blood of patients with craniometaphyseal dysplasia Cell Reprogram. 15 2013 503 513
40. A.E. Grigoriadis et al. Directed differentiation of hematopoietic precursors and functional osteoclasts from human ES and iPS cells Blood 115 2010 2769 2776
41. D. Hashimoto et al. Tissue-resident macrophages self-maintain locally throughout adult life with minimal contribution from circulating monocytes Immunity 38 2013 792 804
42. C. Schulz et al. A lineage of myeloid cells independent of Myb and hematopoietic stem cells Science 336 2012 86 90
43. F. Ginhoux et al. Fate mapping analysis reveals that adult microglia derive from primitive macrophages Science 330 2010 841 845